Opto Circuits is currently trading at Rs. 222.00, up by 6.25 points or 2.90% from its previous closing of Rs. 215.75 on the BSE.
The scrip opened at Rs. 217.50 and has touched a high and low of Rs. 224.80 and Rs. 217.50 respectively. So far 72391 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 310.40 on 09-May-2011 and a 52 week low of Rs. 183.30 on 20-Dec-2011.
Last one week high and low of the scrip stood at Rs. 224.80 and Rs. 204.80 respectively. The current market cap of the company is Rs. 4132.48 crore.
The promoters holding in the company stood at 28.12% while Institutions and Non-Institutions held 38.56% and 33.32% respectively.
Opto Circuits’ subsidiary Criticare Systems Inc which is a global leader in patient monitoring systems secured a contract to supply vital signs monitors to Russia’s third largest province - Tyumen Oblast. The purchase is part of Russia’s nationwide program to upgrade hospital equipment.
The company will be providing nGenuity patient monitors, along with installation and training, to four hospitals including three regional ones as per the agreement developed by Criticare’s Russian distributor, Elmedica. The nGenuity patient monitors are designed for use with both adult and pediatric patients. The hospitals are located in cities of Zavodoukovsk, Yalutorovsk, and the provincial capitol, Tyumen, where many of Russia’s oil and gas companies have headquarters.
Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 534.85 |
| Poly Medicure | 1468.25 |
| Laxmi Denta | 195.10 |
| Nureca Ltd. | 263.80 |
| Hemant Surgical Inds | 297.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: